| Mikulcik, Nicola (Formycon 202206– CBO before Bioeq GmbH + Hexal + Sandoz International) |
Chief Business Officer (CBO) |
Formycon (Group) |
Germany |
| Milad, John E. (ERS Genomics 202405– CEO before Quanta Dialysis Technologies + Nitec Pharma) |
Chief Executive Officer (CEO) |
Quanta Fluid Solutions Ltd. |
United Kingdom (GB) |
| Milde, Heiko (Hamburg (govt) 201208 Managing Director of Innovationsstarter Hamburg GmbH) |
Managing Director |
Hamburg (govt region) |
Germany |
| Miles, Brad (BMC Communications 201803) |
Public Relations Manager / Investor Relations Manager |
PNC Financial Services (Group) |
United States (USA) |
| Miles, Nick (Cabinet Privé de Conseils 202009) |
Public Relations Manager / Investor Relations Manager |
Cabinet Privé de Conseils S.A. |
Switzerland |
| Miles, Nick (Speedel 200301–200802 Director Communications) |
Public Relations Manager / Investor Relations Manager |
Novartis (Group) |
Switzerland |
| Mileski, Dragan (Climedo Health 201705– Managing Director + Co-Founder) |
Managing Director |
Climedo Health GmbH |
Germany |
| Milla, Marcos (Samsara BioCapital 202206 Venture Partner) |
Venture Partner |
Samsara BioCapital (US) |
United States (USA) |
| Miller, Dwayne (Max Planck 201211– Founding Director of MPI for Structure and Dynamics of Matter) |
President/Director/Head Business Group/Unit/Division |
Max Planck Society for the Advancement of Science |
Germany |
| Miller, Kelly (Thermo Fisher 201806 VP/General Manager Laboratory Analytical Reagents) |
General Manager (management) |
Thermo Fisher (Group) |
United States (USA) |
| Miller, Ken (Thermo Fisher 201111– VP Marketing Life Sciences MS before Agilent Marketing Director LC/MS) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
United States (USA) |
| Miller, Rik (DuPont 201410 President DuPont Crop Protection) |
President/Director/Head Business Group/Unit/Division |
DuPont (Group) |
United States (USA) |
| Miller, Thomas (Siemens Healthcare Workflow 200801 CEO) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| Miller, Tom (GreyBird Ventures 201908 Partner + 201908– Board Chairman at GNA Biosolutions) |
Managing Partner (investment firm) |
GreyBird Ventures LLC |
United States (USA) |
| Miller, Walter (Mologen 201604– CFO before Nuvisan Gmbh + Santhera Pharmaceuticals) |
Chief Financial Officer (CFO) |
Mologen (Group) |
Germany |
| Millet, Olivier (Eurazeo 202410 Executive Board and Managing Partner - Small-mid buyout & Nov Santé) |
Managing Partner (investment firm) |
Eurazeo (Group) |
France |
| Millman, Robert (Vesigen Therapeutics 202007 CEO + Co-Founder before Alnylam 200606 Chief IP Councel) |
Chief Executive Officer (CEO) |
Alnylam (Group) |
United States (USA) |
| Mills, Adrian (Novimmune 201409– CBO before GSK since 2000) |
Chief Business Officer (CBO) |
Novimmune S.A. |
Switzerland |
| Mills, Clare (Univ Manchester 201303 Prof at Allergy + Respiratory Centre) |
Professor |
University of Manchester (UoM) |
United Kingdom (GB) |
| Mills, Roger G. (Addex 201611– CMO before Acadia Pharmaceuticals + Pfizer + Gilead + Abbott + Wellcome) |
Chief Medical Officer (CMO) |
Addex (Group) |
Switzerland |
| Milner, Tom (Ametek 201009 SPECTRO) |
Public Relations Manager / Investor Relations Manager |
AMETEK (Group) |
Germany |
| Milosevich, Greg (Danaher 202011 President of Beckman Coulter Life Sciences) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| Miltenyi, Stefan (Miltenyi Biotec 201404 Founder + President) |
President/Director/Head Business Group/Unit/Division |
Miltenyi Biotec (Group) |
Germany |
| Minami, Hiroko (ICN 200810– President) |
n. a. |
International Council of Nurses (ICN) |
Switzerland |
| Minihan, Aoife (Optimum Communications 202412) |
Public Relations Manager / Investor Relations Manager |
Optimum Strategic Communications |
United Kingdom (GB) |
| Minkewitz, Christine (Campus Berlin-Buch 202210 Location Marketing) |
Sales Manager / Marketing Manager |
Campus Berlin-Buch GmbH |
Germany |
| Minkova, Miroslava (Vertex 202303 Investor Relations formerly Bruker Corp 201611 Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Vertex Pharmaceuticals (Group) |
United States (USA) |
| Minotta, Mauricio (Thermo Fisher 201511) |
public relations / investor relations |
Thermo Fisher (Group) |
United States (USA) |
| Mintun, Mark (Lilly 201812 VP Neurodegeration + Pain Research) |
Research & Development Manager |
Eli Lilly (Group) |
United States (USA) |
| Miralles, Diego (Flagship Pioneering 202102– CEO-Partner + CEO of Laronde before Vividion Tx +Adaptive Tx + JnJ) |
Chief Executive Officer (CEO) |
Laronde Inc. |
United States (USA) |
| Miras, Stéphane (Kelly Services 202110– promoted to Director Life Sciences CH + Swiss Leadership Team joined 2008) |
President/Director/Head Business Group/Unit/Division |
Kelly Services (Group) |
Switzerland |
| Mirovsky, Pavel (PharmaSwiss 201102 CEO) |
Chief Executive Officer (CEO) |
Valeant (Group) |
Switzerland |
| Mischau, Reinhold (Peqlab Biotechnologie GmbH 200710 Managing Director) |
Managing Director |
Avantor (Group) |
Germany |
| Miserez, André (Diagene 201104 CEO) |
Chief Executive Officer (CEO) |
Diagene (Group) |
Switzerland |
| Mishlawi, Riad (Hikma 202406 CEO) |
Chief Executive Officer (CEO) |
Hikma (Group) |
United Kingdom (GB) |
| Mistry, Jehangir (Merck (DE) 201201 Director RnD at EMD Millipore) |
Research & Development Manager |
Merck (DE) (Group) |
United States (USA) |
| Mita, Masayuki (Takasago 201412 SVP Fragrance + Aroma Chemical Division) |
President/Director/Head Business Group/Unit/Division |
Takasago International Corporation |
Japan |
| Mitan, Ania (SIRS-Lab 200812– Executive VP Commercial before Eli Lilly European Marketing Director) |
Sales Manager / Marketing Manager |
Endress+Hauser (Group) |
Germany |
| Mitchell, Rob (Roche 200904 Global Head Virology Business) |
Product Manager (personnel) |
Roche (Group) |
Switzerland |
| Mitterlehner, Reinhold (Austria (govt) 201210 Minister of Economy) |
Minister |
Austria (govt) |
Austria |
| Mittmann, Laura (Trophic Communications 202002) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Miura, Yasuo (Shimadzu 201304 Managing Director of Shimadzu Europa GmbH) |
Managing Director |
Shimadzu (Group) |
Germany |
| Mix, Guido (Bruker 200905 Bruker Daltonik Director Business Development MALDI Biotyper) |
Business Development Manager / Strategy Manager |
Bruker (Group) |
Germany |
| Mixtacki, Heiko (Biostep GmbH 200709) |
n. a. |
Biostep GmbH |
Germany |
| Mizoue, Laura S. (201904 SomaLogic) |
Public Relations Manager / Investor Relations Manager |
Standard BioTools (Group) |
United States (USA) |
| Mizrahi, Jacques (Aravis + INSERM + ElsaLys 201701 Consultant before Roche 200512 Head of Metabolic + Vascular Diseases) |
Venture Partner |
Aravis (Group) |
Switzerland |
| Mlodzianowski, Werner |
n. a. |
Bremerhaven University of Applied Sciences (Hochschule Bremerhaven) |
Germany |
| Moarefi, Ismail (Crelux 200502– co-founder) |
Company Founder |
WuXi PharmaTech (Group) |
Germany |
| Modersitzki, Jan (Univ Lübeck 201004 Professor) |
Professor |
University of Lübeck (Universität zu Lübeck, UzL) |
Germany |
| Modes, Ralf (Askion 201303 Managing Director) |
Managing Director |
Askion (Group) |
Germany |
| Modig, Berndt (Pharvaris CEO before Prosensa 201003 CFO before Jerini 200310– CFO before Surplex AG) |
Chief Executive Officer (CEO) |
Pharvaris B.V. |
Netherlands |
| Modis, Louise (Mogrify 202110– CSO before GSK + Sitryx + Boehringer Ingelheim Pharma + Millennium Pharma) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Mogrify (Group) |
United Kingdom (GB) |
| Modregger, Jan (Eucodis Bioscience 202208 CEO) |
Chief Executive Officer (CEO) |
Biosynth (since 9/22) (Group) |
Austria |
| Moebius, Ulrich (MorphoSys 200902– Head Pre-clinical develop before Medigene) |
Research & Development Manager |
Novartis (Group) |
Germany |
| Moedas, Carlos (EU (govt) 201710 Commissioner for Research, Science + Innovation) |
Minister |
EU (govt) |
Luxembourg |
| Moeinzadeh, Hossein (Lucid Genomics 202409 CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
Lucid Genomics GmbH |
Germany |
| Moelker, Adriaan (BRAIN 202002– CEO before Flint Group + AB Enzymes + Genencor + DSM) |
Chief Executive Officer (CEO) |
BRAIN Biotech (Group) |
Germany |
| Moellgaard, Henrik (Direvo Industrial Biotech 200807– before Christian Hansen) |
n. a. |
Direvo Industrial Biotechnology (Group) |
Germany |
| Moesslang, Angelo (InGeneron 201710– CEO before CFO at Fresenius Medial Care North America) |
Chief Executive Officer (CEO) |
InGeneron (Group) |
Germany |
| Mohadjer, Aydin (CAMAG 201302 Corporate Marketing Manager) |
Sales Manager / Marketing Manager |
CAMAG (Group) |
Switzerland |
| Mohan, Vikalp (Celonic 2021102 CBO 201609 VP Global Commercial Operations) |
Sales Manager / Marketing Manager |
Celonic (Group) |
Switzerland |
| Mohr, Bernhard (Evonik 201201– Head of Corporate Venturing) |
President/Director/Head Business Group/Unit/Division |
Evonik (Group) |
Germany |
| Mohr, Deana (Muvon Therapeutics 202104 CEO + Co-Founder) |
Chief Medical Officer (CMO) |
Muvon Therapeutics AG |
Switzerland |
| Mohr, Fabian (High-Tech Gründerfonds 201811) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Mohr, Heribert (Thermo Fisher 201304– Global Strategic BusDev Manager Chromatography + MS division) |
Business Development Manager / Strategy Manager |
Thermo Fisher (Group) |
Germany |
| Mohr, Lars (berlinbiotechpark 201104 Managing Director) |
Managing Director |
berlinbiotechpark GmbH & Co. KG |
Germany |
| Mohr, Mareike (MC Services 201207 Public Relations) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Mohr, Ulrich (Cultex Laboratories GmbH 201105 Managing Director + co-founder) |
Managing Director |
Cultex Laboratories GmbH |
Germany |
| Moingeon, Benjamin (GATC Biotech 201503 Sales Director) |
Sales Manager / Marketing Manager |
Eurofins (Group) |
Germany |
| Mol, Jan Willem (ModuVision Technologies 202206 CEO) |
Chief Executive Officer (CEO) |
Knauer (Group) |
Netherlands |
| Moldenbauer, Gerhard |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Moll, Fred (Ciruit Therapeutics 201312 Chairman) |
Board member |
Circuit Therapeutics Inc. |
United States (USA) |
| Moll, Gert (Lanthio Pharma 201410 CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Netherlands |
| Moll, Nathalie (EFPIA 201704– Director General before Secretary General at EuropaBio) |
President/Director/Head Business Group/Unit/Division |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
| Moll, Peter (Otsuka 201103 Managing Director of ABX GmbH) |
Managing Director |
Otsuka (Group) |
Germany |
| Momsen, Björn (High-Tech Gründerfonds 201010 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Monaghan, Paul (Psyros Diagnostics 202201 Head of Engineering + Co-Founder before Novartis NPTU/Vivacta) |
Chief Technology/Technical Officer (CTO) |
Prolight Diagnostics (Group) |
United Kingdom (GB) |
| Monin, Jean-Fabien (AC Immune 200901– CFO before 14y at bioMérieux CFO Central Europe) |
Chief Financial Officer (CFO) |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
| Monko, Michael (Sequenom 200608– Senior VP Sales + Marketing before UpState Chemicon before Invitrogen Corp) |
n. a. |
LabCorp (Group) |
United States (USA) |
| Monroe, Thomas Lawrence (Tom) (Actelion 201604 CEO of Vaxxilon AG) |
Chief Executive Officer (CEO) |
Idorsia (Group) |
Switzerland |
| Montag, Bernd (Siemens 201802 CEO of Siemens Healthineers) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| Montagner, Carlo (200801– CEO + Founder of STA before Alchemia + Abraxas Bioscience et al + Schering 200510) |
Chief Executive Officer (CEO) |
Specialised Therapeutics Australia Pty Ltd. (STA) |
Australia |
| Montana, John (Oxitope Pharma 202109– CEO joined as COO 4/20 also Operating Partner at Forbion before Charles River) |
Chief Executive Officer (CEO) |
Calluna Pharma (Group) |
Netherlands |
| Montanari, Bruno (Seroba Life Sciences 201905 before Omnes Capital 201607 Partner) |
Partner (venture partner) |
Seroba (Group) |
Ireland, Republic of |
| Monteiro, Leonor (Ori Biotech 202501– SVP Finance before Novartis) |
Financial Manager (CFO, Financial Director, etc.) |
Ori Biotech (Oribiotech) (Group) |
United Kingdom (GB) |
| Montenbruck, Ingo (Ingenium 200606 Senior Director BusDev) |
Business Development Manager / Strategy Manager |
Vivoryon (Group) |
Germany |
| Montero-MacColl, James (EasyFairs 202302 Senior Marketing Manager at EasyFairs UK) |
Sales Manager / Marketing Manager |
Artexis (Group) |
United Kingdom (GB) |
| Montserrat, Jordi (Venturelab 202403 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Venturelab AG (CH) |
Switzerland |
| Monz, Ludwin (Carl Zeiss 201401 CEO of Carl Zeiss Medictec AG) |
Chief Executive Officer (CEO) |
Carl Zeiss (Group) |
Germany |
| Moonen, Kees (Kreatech 200909– CEO before Green Cross Vaccine CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
Netherlands |
| Moore, Brad (Roche 202404 CEO of Roche Diagnostics Corp + Head of North America Region Roche Diagnostics) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Moore, Jeffrey R. (Helicos 201208 SVP + CFO) |
Chief Financial Officer (CFO) |
Helicos BioSciences Corporation (Nasdaq: HLCS) |
United States (USA) |
| Moore, John (Scientific Industries 202104 Chairman + President of SBI) |
President/Director/Head Business Group/Unit/Division |
Scientific Industries (Group) |
United States (USA) |
| Moore, Judith (AC Immune 202003 Global Head of Communications) |
Public Relations Manager / Investor Relations Manager |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
| Moore, Kevin (Tecan 201011 Director Market and Application Management for BioPharma) |
Product Manager (personnel) |
Tecan (Group) |
Switzerland |
| Moosbauer, Julia (Deepc 202303 COO + Co-Founder) |
Chief Operating Officer (COO) |
Deepc GmbH |
Germany |
| Mora, Karla (Alante Capital 202405 Managing Partner + Co-Founder) |
Managing Partner (investment firm) |
Alante Capital (US) |
United States (USA) |
| Mora, Luis (Zeltia 201208– Managing Director of newly founded Pharma Mar GmbH) |
Managing Director |
PharmaMar (Group) |
Germany |
| Moradian, Eddie (MD Biosiences 202010 CEO) |
Chief Executive Officer (CEO) |
MLM Medical Labs (Group) |
United States (USA) |
| Morand, Olivier (Azafaros 201807– CEO before Idorsia + Actelion + Roche) |
Chief Executive Officer (CEO) |
Azafaros B.V. |
Netherlands |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 55 56 57 ... 94 95 96 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
